Why lecanemab’s success spells the revival of small-molecule Alzheimer’s treatments
Unlike bulky biologics, small molecules can make Alzheimer’s treatments cheap, convenient to administer, and widely accessible, experts say
Source: Chemical and Engineering News - Category: Chemistry Authors: Shi En Kim Source Type: research
More News: Chemistry